Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
|
1. What is the DOC for anaphylactic shock?
|
a. Epinephrine
|
|
|
2. What is the MOA of epinephrine?
|
a. Non-selective a and B agonist
b. a1, a2, B1, B2, B3 |
|
|
3. What are the adrenergic agonists?
|
a. Epinephrine/NE
b. Phenylephrine c. Methyldopa d. Isoproterenol e. Dobutamine/dopamine f. Fenoldopam |
|
|
4. What is the MOA of NE?
|
a. Non-selective a and B agonist
b. a1, a2, B1 |
|
|
5. What is the use of phenylephrine?
|
a. Control hemorrhage
b. Delay absorption of local anesthetics c. Nasal congestion d. Hypotensive crisis |
|
|
1. What is the MOA of phenylephrine?
|
a. Selective a1 agonist
|
|
|
7. What is the use of methyldopa?
|
a. HTN
|
|
|
8. What is the MOA of methyldopa?
|
a. Selective a2 agonist→ decreases sympathetic outflow
|
|
|
9. What is the advantage of methyldopa?
|
a. Pregnancy category B-- GOOD
|
|
|
10. What is the use of isoproterenol?
|
a. AV block
b. Stokes-Adams attack c. Bradycardia |
|
|
11. What is the MOA of isoproterenol?
|
a. Non-selective B agonist
|
|
|
12. What is the use of dobutamine?
|
a. Severe CHF
b. Cardiogenic shock c. Septic shock |
|
|
13. What is the MOA of dobutamine?
|
a. Selective B1 agonist
|
|
|
14. What is the use of dopamine?
|
a. Severe CHF-- short term
b. Cardiogenic shock c. Septic shock |
|
|
15. What is the target of low dose dopamine?
|
a. DA-1 receptors
|
|
|
16. What is the target of intermediate dose dopamine?
|
a. B1 receptors
|
|
|
17. What is the target of high dose dopamine?
|
a. a1 receptors
|
|
|
18. What is the MOA of dopamine?
|
a. Non-selective DA agonist
|
|
|
19. What is the use of fenoldopam?
|
a. HTN crisis
|
|
|
20. What is the MOA of fenoldopam?
|
a. Selective DA-1 agonist
|
|
|
21. What is the adverse effect of fenoldopam?
|
a. Reflex tachycardia
|
|
|
22. What is the use of phenoxybenzamine?
|
a. Pheochromocytoma DOC
b. Vasodilation |
|
|
23. What is the MOA of phenoxybenzamine?
|
a. Non-selective a antagonist
b. Competitive and irreversible |
|
|
24. What is the use of phentolamine?
|
a. Pheochromocytoma
b. HTN crisis caused by decreased MAOI c. Vasodilation d. Cardiac stimulation |
|
|
25. What is the MOA of phentolamine?
|
a. Non-selective a antagonist
b. Competitive and reversible |
|
|
26. What is the use of prazosin/terazosin/doxazosin?
|
a. Pheochromocytoma
b. Chronic HTN (not DOC) c. Urinary retention in BPH |
|
|
27. What is the MOA of prazosin/terazosin/doxazosin?
|
a. Selective a1 antagonist
b. Vasodilation→ decrease BP c. Lower LDL and TAGs while increasing HDL |
|
|
28. What is the adverse effect of prazosin/terazosin/doxazosin?
|
a. First dose syncope
|
|
|
29. What is the use of propranolol?
|
b. Ischemic heart diseases
c. Arrhythmias d. CHF |
|
|
30. What is the MOA of propranolol?
|
a. Non-selective B antagonist
|
|
|
31. What is the contraindication of propranolol?
|
a. Asthma
b. Diabetes |
|
|
32. What is the use of metoprolol/bisoprolol?
|
a. HTN
b. Ischemic heart diseases c. Arrhythmias d. CHF |
|
|
33. What is the MOA of metoprolol/bisoprolol?
|
a. Selective B1 antagonists
|
|
|
34. What is the use of Labetalol?
|
a. HTN crisis
b. HTN |
|
|
35. What is the MOA of labetalol?
|
a. a and B antagonists
|
|
|
36. What is the use of carvedilol?
|
a. Chronic HF DOC
b. HTN |
|
|
37. What is the MOA of carvedilol?
|
a. a and B antagonist
b. Anti-oxidant and anti-proliferative effects |
|
|
38. Where does the PNS have predominant tone?
|
a. SA node
|
|
|
39. Where does the SNS have predominant tone?
|
a. Arterioles
b. Veins c. Heart/ventricles |
